Human Albumin CSL Behring 200 g/l inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

human albumin csl behring 200 g/l inf. sol. i.v. vial

csl behring gmbh - albumin human 200 g/l - solution for infusion - 200 g/l - albumin human 200 g/l - albumin

Water for Injection CSL Behring parent. solv. parent. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

water for injection csl behring parent. solv. parent. vial

csl behring gmbh - water for injection 2 ml - solvent for parenteral use - solvents and diluting agents, incl. irrigating solutions

Water for Injection CSL Behring parent. solv. parent. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

water for injection csl behring parent. solv. parent. vial

csl behring gmbh - water for injection 2 ml - solvent for parenteral use - solvents and diluting agents, incl. irrigating solutions

BERINERT IV human C1 esterase inhibitor 1500 IU powder for injection vial with diluent vial Australia - English - Department of Health (Therapeutic Goods Administration)

berinert iv human c1 esterase inhibitor 1500 iu powder for injection vial with diluent vial

csl behring australia pty ltd - water for injections, quantity: 3 ml - injection, diluent for - excipient ingredients: - berinert iv is indicated for the treatment of acute attacks in patients with hereditary angioedema (hae).

BERINERT IV human C1 esterase inhibitor 500 IU powder for injection vial with diluent vial Australia - English - Department of Health (Therapeutic Goods Administration)

berinert iv human c1 esterase inhibitor 500 iu powder for injection vial with diluent vial

csl behring australia pty ltd - water for injections, quantity: 10 ml - injection, diluent for - excipient ingredients: - berinert iv is indicated for the treatment of acute attacks in patients with hereditary angioedema (hae).

BERINERT SC  Human C1 esterase inhibitor 3000 IU powder for injection glass vial with diluent vial Australia - English - Department of Health (Therapeutic Goods Administration)

berinert sc human c1 esterase inhibitor 3000 iu powder for injection glass vial with diluent vial

csl behring australia pty ltd - c1 esterase inhibitor, quantity: 3000 iu - injection, diluent for - excipient ingredients: - berinert? sc for subcutaneous injection is indicated for prevention of recurrent hereditary angioedema (hae) attacks in patients aged 8 years and older with c1 esterase inhibitor deficiency.

BERINERT SC  Human C1 esterase inhibitor 2000 IU powder for injection glass vial with diluent vial Australia - English - Department of Health (Therapeutic Goods Administration)

berinert sc human c1 esterase inhibitor 2000 iu powder for injection glass vial with diluent vial

csl behring australia pty ltd - c1 esterase inhibitor, quantity: 2000 iu - injection, diluent for - excipient ingredients: - berinert? sc for subcutaneous injection is indicated for prevention of recurrent hereditary angioedema (hae) attacks in patients aged 8 years and older with c1 esterase inhibitor deficiency.

Medicine administration kit, percutaneous, medicated, single-use Australia - English - Department of Health (Therapeutic Goods Administration)

medicine administration kit, percutaneous, medicated, single-use

csl behring australia pty ltd - 45156 - medicine administration kit, percutaneous, medicated, single-use - the procedure pack consists of: mix2vial, venipuncture set, disposable 10ml syringe, alcohol swabs and plaster/adhesive bandage. the mix2vial is used to transfer the diluent from the diluent vial to the medicine vial. the reconstituted medicine is drawn through the mix2vial into the syringe. the syringe containing the medicine is then connected to the venipuncture set to facilitate intravenous injection of the medicine. alcohol swabs are provided to wipe the rubber stopper of each vial before the mix2vial is applied. the plaster/adhesive bandage is provided to cover the injection site after administration of medicine.